Search type: go_term
Results for query: positive regulation of apoptotic process
Gene Symbol | Gene Name | Links to Senescence |
---|---|---|
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
ABR | ABR activator of RhoGEF and GTPase |
U: 2
|
ACVR1C | activin A receptor, type IC |
U: 1
|
ADAM10 | a disintegrin and metallopeptidase domain 10 |
U: 3
D: 2
|
ADAMTSL4 | ADAMTS-like 4 |
U: 3
|
ADCY10 | adenylate cyclase 10 |
U: 1
|
ADM | adrenomedullin |
U: 4
D: 2
|
AIFM2 | apoptosis-inducing factor, mitochondrion-associated 2 |
D: 1
|
AKAP13 | A-kinase anchoring protein 13 |
U: 1
|
AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
ALDH1A2 | aldehyde dehydrogenase family 1, subfamily A2 |
D: 2
|
ALDH1A3 | aldehyde dehydrogenase family 1, subfamily A3 |
U: 6
|
ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) |
U: 3
D: 2
|
ANO6 | anoctamin 6 |
U: 1
|
APAF1 | apoptotic peptidase activating factor 1 |
U: 1
D: 1
|
APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 |
U: 1
|
APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 |
U: 1
D: 1
|
APC | APC, WNT signaling pathway regulator |
D: 2
|
APH1A | aph-1 homolog A, gamma-secretase subunit |
D: 1
|
ARHGEF12 | Rho guanine nucleotide exchange factor 12 |
U: 1
|
ARHGEF16 | Rho guanine nucleotide exchange factor 16 |
U: 3
|
ARHGEF17 | Rho guanine nucleotide exchange factor 17 |
D: 1
|
ARHGEF19 | Rho guanine nucleotide exchange factor 19 |
U: 2
|
ARHGEF2 | Rho/Rac guanine nucleotide exchange factor 2 |
D: 3
|
ARHGEF26 | Rho guanine nucleotide exchange factor 26 |
U: 1
D: 2
|
ARHGEF3 | Rho guanine nucleotide exchange factor 3 |
U: 1
|
ARHGEF4 | Rho guanine nucleotide exchange factor 4 |
U: 2
|
ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor 6 |
D: 1
|
ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 |
U: 3
|
ATF4 | activating transcription factor 4 |
U: 2
D: 1
|
ATF6 | activating transcription factor 6 |
U: 4
|
ATG7 | autophagy related 7 |
U: 3
D: 4
|
ATM | ataxia telangiectasia mutated |
U: 28
D: 1
|
ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
ACIN1 | apoptotic chromatin condensation inducer 1 |
D: 2
|
ADAM17 | a disintegrin and metallopeptidase domain 17 |
U: 3
D: 2
|
ADRB2 | adrenergic receptor, beta 2 |
U: 1
D: 1
|
AGER | advanced glycosylation end product-specific receptor |
U: 2
D: 1
|
ALDH1A1 | aldehyde dehydrogenase family 1, subfamily A1 |
U: 2
D: 1
|
ALOX12 | arachidonate 12-lipoxygenase |
U: 1
|
ANXA1 | annexin A1 |
U: 2
D: 1
|
ANXA5 | annexin A5 |
U: 1
D: 1
|
APP | amyloid beta (A4) precursor protein |
U: 6
D: 2
|
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
U: 2
|
BAK1 | BCL2-antagonist/killer 1 |
U: 4
D: 1
|
BARD1 | BRCA1 associated RING domain 1 |
U: 1
D: 4
|
BAX | BCL2-associated X protein |
U: 7
|
BBC3 | BCL2 binding component 3 |
U: 4
D: 1
|
BCL10 | B cell leukemia/lymphoma 10 |
U: 1
D: 1
|
BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
U: 1
|
BCL6 | B cell leukemia/lymphoma 6 |
U: 3
D: 1
|
BCLAF1 | BCL2-associated transcription factor 1 |
D: 1
|
BID | BH3 interacting domain death agonist |
U: 5
|
BIN1 | bridging integrator 1 |
U: 1
D: 1
|
BMF | BCL2 modifying factor |
U: 4
D: 2
|
BMP2 | bone morphogenetic protein 2 |
U: 6
D: 1
|
BMP4 | bone morphogenetic protein 4 |
U: 5
D: 1
|
BMP7 | bone morphogenetic protein 7 |
U: 5
D: 3
|
BNIP3L | BCL2/adenovirus E1B interacting protein 3-like |
U: 3
|
BOK | BCL2-related ovarian killer |
U: 3
D: 1
|
BCL2L1 | BCL2-like 1 |
U: 11
D: 7
|
BCL2L10 | Bcl2-like 10 |
U: 1
|
C1QBP | complement component 1, q subcomponent binding protein |
U: 1
D: 3
|
CASP2 | caspase 2 |
U: 2
D: 1
|
CASP3 | caspase 3 |
U: 3
D: 5
|
CASP9 | caspase 9 |
U: 1
|
CCAR1 | cell division cycle and apoptosis regulator 1 |
D: 1
|
CCAR2 | cell cycle activator and apoptosis regulator 2 |
U: 1
D: 1
|
CDK4 | cyclin-dependent kinase 4 |
U: 1
D: 17
|
CLIP3 | CAP-GLY domain containing linker protein 3 |
U: 4
|
CLU | clusterin |
U: 3
D: 5
|
CNR1 | cannabinoid receptor 1 (brain) |
D: 1
|
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain |
U: 1
D: 2
|
CREB1 | cAMP responsive element binding protein 1 |
D: 2
|
CSRNP3 | cysteine-serine-rich nuclear protein 3 |
U: 1
|
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
U: 1
|
CTNNB1 | catenin (cadherin associated protein), beta 1 |
U: 7
D: 2
|
CTSD | cathepsin D |
U: 4
D: 2
|
CYP1B1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
U: 5
D: 1
|
CASP1 | caspase 1 |
U: 2
D: 3
|
CASP8 | caspase 8 |
U: 1
D: 2
|
CCN1 | cellular communication network factor 1 |
U: 4
D: 2
|
CDKN2A | cyclin dependent kinase inhibitor 2A |
U: 238
D: 5
|
DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
DAPK1 | death associated protein kinase 1 |
U: 2
D: 1
|
DAPK2 | death-associated protein kinase 2 |
U: 3
|
DAPK3 | death-associated protein kinase 3 |
U: 2
|
DCUN1D3 | DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
U: 2
|
DHODH | dihydroorotate dehydrogenase |
D: 1
|
DIABLO | diablo, IAP-binding mitochondrial protein |
U: 1
|
DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 |
U: 1
D: 2
|
DNM1L | dynamin 1-like |
U: 1
D: 6
|
DNM2 | dynamin 2 |
U: 1
|
DUSP1 | dual specificity phosphatase 1 |
U: 4
D: 5
|
DUSP6 | dual specificity phosphatase 6 |
D: 2
|
DUSP9 | dual specificity phosphatase 9 |
U: 1
|
DAXX | Fas death domain-associated protein |
D: 1
|
DDIT3 | DNA-damage inducible transcript 3 |
U: 6
D: 1
|
DEGS1 | delta(4)-desaturase, sphingolipid 1 |
U: 1
|
E2F1 | E2F transcription factor 1 |
U: 6
D: 13
|
ECT2 | ect2 oncogene |
D: 3
|
EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 |
U: 2
D: 1
|
EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 |
U: 2
D: 1
|
EIF2B5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon |
D: 1
|
ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 |
U: 1
|
EFHC1 | EF-hand domain (C-terminal) containing 1 |
U: 1
D: 1
|
EGLN1 | egl-9 family hypoxia-inducible factor 1 |
U: 1
|
EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 |
U: 2
|
EIF5A | eukaryotic translation initiation factor 5A |
D: 1
|
ENDOG | endonuclease G |
U: 1
D: 1
|
EPHA7 | Eph receptor A7 |
D: 2
|
ERBB4 | erb-b2 receptor tyrosine kinase 4 |
U: 2
D: 1
|
ESR2 | estrogen receptor 2 (beta) |
U: 2
D: 1
|
FAF1 | Fas associated factor 1 |
D: 1
|
FAM162A | family with sequence similarity 162, member A |
U: 2
D: 1
|
FANK1 | fibronectin type 3 and ankyrin repeat domains 1 |
U: 2
|
FAS | Fas (TNF receptor superfamily member 6) |
U: 4
D: 1
|
FASLG | Fas ligand |
U: 3
|
FGD3 | FYVE, RhoGEF and PH domain containing 3 |
U: 2
D: 1
|
FGD4 | FYVE, RhoGEF and PH domain containing 4 |
U: 2
|
FLCN | folliculin |
U: 1
|
FOSL1 | fos-like antigen 1 |
U: 1
D: 3
|
FOXA1 | forkhead box A1 |
U: 3
|
FOXL2 | forkhead box L2 |
U: 1
|
FOXO1 | forkhead box O1 |
U: 10
D: 4
|
FOXO3 | forkhead box O3 |
U: 6
D: 10
|
FRZB | frizzled-related protein |
U: 1
D: 3
|
FZD9 | frizzled class receptor 9 |
U: 1
|
FAM72A | family with sequence similarity 72, member A |
D: 1
|
FOLH1 | folate hydrolase 1 |
U: 1
|
GADD45A | growth arrest and DNA-damage-inducible 45 alpha |
U: 7
D: 1
|
GADD45B | growth arrest and DNA-damage-inducible 45 beta |
U: 5
D: 2
|
GADD45G | growth arrest and DNA-damage-inducible 45 gamma |
U: 4
D: 1
|
GAL | galanin and GMAP prepropeptide |
U: 2
|
GNA13 | G protein subunit alpha 13 |
U: 2
|
GPER1 | G protein-coupled estrogen receptor 1 |
U: 1
D: 1
|
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 |
U: 2
|
GRIN1 | glutamate receptor, ionotropic, NMDA1 (zeta 1) |
U: 1
|
GRIN2A | glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
U: 1
|
GATA6 | GATA binding protein 6 |
U: 4
D: 1
|
GSK3B | glycogen synthase kinase 3 beta |
U: 1
D: 6
|
HMGA2 | high mobility group AT-hook 2 |
U: 3
D: 2
|
HMGB1 | high mobility group box 1 |
U: 5
D: 8
|
HMOX1 | heme oxygenase 1 |
U: 5
D: 6
|
HOXA5 | homeobox A5 |
D: 1
|
HPGD | hydroxyprostaglandin dehydrogenase 15 (NAD) |
U: 2
|
HSPD1 | heat shock protein 1 (chaperonin) |
U: 1
D: 3
|
HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
ID3 | inhibitor of DNA binding 3 |
U: 2
D: 7
|
IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
U: 3
|
IGF2R | insulin-like growth factor 2 receptor |
U: 2
D: 2
|
IGFBP3 | insulin-like growth factor binding protein 3 |
U: 19
D: 4
|
IL6 | interleukin 6 |
U: 97
D: 20
|
ING3 | inhibitor of growth family, member 3 |
D: 3
|
ING4 | inhibitor of growth family, member 4 |
U: 1
D: 1
|
ING5 | inhibitor of growth family, member 5 |
U: 2
D: 1
|
INPP5D | inositol polyphosphate-5-phosphatase D |
U: 2
D: 1
|
IP6K2 | inositol hexaphosphate kinase 2 |
U: 1
|
IRF5 | interferon regulatory factor 5 |
U: 4
D: 1
|
ITGB1 | integrin beta 1 (fibronectin receptor beta) |
U: 3
D: 1
|
ITGB3BP | integrin subunit beta 3 binding protein |
D: 2
|
ITSN1 | intersectin 1 |
D: 2
|
IDO1 | indoleamine 2,3-dioxygenase 1 |
U: 1
D: 3
|
IFNG | interferon gamma |
U: 13
|
IL18 | interleukin 18 |
U: 8
D: 1
|
IL1B | interleukin 1 beta |
U: 48
D: 9
|
IL24 | interleukin 24 |
U: 2
|
ITPR1 | inositol 1,4,5-trisphosphate receptor 1 |
U: 5
D: 2
|
JMY | junction-mediating and regulatory protein |
U: 2
|
JUN | jun proto-oncogene |
U: 4
D: 7
|
JAK2 | Janus kinase 2 |
U: 3
|
KALRN | kalirin RhoGEF kinase |
U: 1
D: 1
|
KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
U: 1
D: 1
|
KNG1 | kininogen 1 |
U: 2
|
KLRK1 | killer cell lectin-like receptor subfamily K, member 1 |
U: 1
D: 1
|
LATS1 | large tumor suppressor |
D: 2
|
LATS2 | large tumor suppressor 2 |
U: 2
D: 2
|
LDHA | lactate dehydrogenase A |
U: 5
D: 2
|
LPAR1 | lysophosphatidic acid receptor 1 |
D: 5
|
LTA | lymphotoxin A |
U: 1
|
LRP6 | low density lipoprotein receptor-related protein 6 |
D: 1
|
MAP2K6 | mitogen-activated protein kinase kinase 6 |
U: 1
D: 4
|
MAP3K10 | mitogen-activated protein kinase kinase kinase 10 |
U: 1
|
MAP3K11 | mitogen-activated protein kinase kinase kinase 11 |
U: 1
|
MAP3K20 | mitogen-activated protein kinase kinase kinase 20 |
D: 3
|
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
U: 1
D: 1
|
MAP3K9 | mitogen-activated protein kinase kinase kinase 9 |
U: 4
D: 2
|
MAPK8 | mitogen-activated protein kinase 8 |
U: 5
D: 3
|
MCF2 | MCF.2 cell line derived transforming sequence |
U: 1
|
MCF2L | MCF.2 cell line derived transforming sequence like |
D: 1
|
MELK | maternal embryonic leucine zipper kinase |
D: 4
|
MIR137 | microRNA 137 |
U: 1
|
MIR146A | microRNA 146a |
U: 2
D: 5
|
MIR15B | microRNA 15b | |
MIR16-1 | microRNA 16-1 |
U: 1
|
MIR19B1 | microRNA 19b-1 |
U: 1
|
MIR21 | microRNA 21 |
U: 2
D: 1
|
MIR221 | microRNA 221 |
D: 1
|
MIR29A | microRNA 29a |
U: 3
|
MIR29B1 | microRNA 29b-1 |
U: 2
|
MIR29C | microRNA 29c |
U: 2
D: 1
|
MLLT11 | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 |
U: 2
D: 2
|
MOAP1 | modulator of apoptosis 1 |
U: 1
|
MTCH1 | mitochondrial carrier 1 |
U: 1
|
MAP2K4 | mitogen-activated protein kinase kinase 4 |
U: 2
|
MAPK9 | mitogen-activated protein kinase 9 |
U: 1
D: 3
|
MEN1 | multiple endocrine neoplasia 1 |
U: 1
D: 1
|
MMP2 | matrix metallopeptidase 2 |
U: 12
D: 2
|
MMP9 | matrix metallopeptidase 9 |
U: 14
D: 3
|
MSX2 | msh homeobox 2 |
U: 1
D: 3
|
MYC | myelocytomatosis oncogene |
U: 7
D: 24
|
NCSTN | nicastrin |
U: 1
|
NET1 | neuroepithelial cell transforming gene 1 |
D: 1
|
NEURL1 | neuralized E3 ubiquitin protein ligase 1 |
U: 1
|
NEUROD1 | neurogenic differentiation 1 |
D: 1
|
NF1 | neurofibromin 1 |
U: 2
D: 2
|
NGEF | neuronal guanine nucleotide exchange factor |
U: 1
D: 2
|
NGF | nerve growth factor |
U: 3
|
NGFR | nerve growth factor receptor (TNFR superfamily, member 16) |
U: 2
|
NLRC4 | NLR family, CARD domain containing 4 |
U: 2
|
NOTCH1 | notch 1 |
U: 8
D: 5
|
NOX4 | NADPH oxidase 4 |
U: 18
D: 2
|
NSMAF | neutral sphingomyelinase (N-SMase) activation associated factor |
U: 1
D: 1
|
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 |
U: 2
|
NTSR1 | neurotensin receptor 1 |
U: 1
D: 2
|
NELL1 | NEL-like 1 |
U: 1
D: 2
|
NFATC4 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
U: 2
D: 1
|
NOS3 | nitric oxide synthase 3, endothelial cell |
U: 5
D: 13
|
NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
U: 2
|
NUPR1 | nuclear protein transcription regulator 1 |
U: 6
D: 2
|
OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
U: 1
D: 2
|
OLFM1 | olfactomedin 1 |
U: 2
D: 1
|
OSGIN1 | oxidative stress induced growth inhibitor 1 |
U: 2
D: 1
|
P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
D: 1
|
PAWR | PRKC, apoptosis, WT1, regulator |
U: 1
D: 2
|
PDCD5 | programmed cell death 5 |
U: 1
D: 1
|
PDGFRB | platelet derived growth factor receptor, beta polypeptide |
D: 4
|
PHLDA1 | pleckstrin homology like domain, family A, member 1 |
U: 2
D: 2
|
PHLDA2 | pleckstrin homology like domain family A member 2 |
U: 2
D: 1
|
PHLDA3 | pleckstrin homology like domain, family A, member 3 |
U: 1
D: 1
|
PIDD1 | p53-induced death domain protein 1 |
U: 3
|
PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 |
D: 1
|
PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 |
U: 1
|
PLEKHN1 | pleckstrin homology domain containing, family N member 1 |
U: 1
D: 2
|
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
U: 5
D: 1
|
PNMA1 | PNMA family member 1 |
D: 1
|
PNMA2 | PNMA family member 2 |
U: 1
D: 1
|
POU4F1 | POU domain, class 4, transcription factor 1 |
D: 1
|
PPID | peptidylprolyl isomerase D (cyclophilin D) |
U: 1
D: 1
|
PREX1 | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 |
U: 2
D: 2
|
PRKDC | protein kinase, DNA activated, catalytic polypeptide |
U: 1
D: 4
|
PRR7 | proline rich 7 (synaptic) |
U: 1
D: 1
|
PSEN1 | presenilin 1 |
U: 3
|
PSEN2 | presenilin 2 |
U: 1
|
PSENEN | presenilin enhancer, gamma-secretase subunit |
U: 1
D: 1
|
PTGS2 | prostaglandin-endoperoxide synthase 2 |
U: 12
D: 4
|
PTN | pleiotrophin |
U: 2
D: 6
|
PTPA | protein phosphatase 2 protein activator |
U: 1
|
PYCARD | PYD and CARD domain containing |
U: 1
|
PDCD1 | programmed cell death 1 |
U: 1
D: 1
|
PDE5A | phosphodiesterase 5A, cGMP-specific |
U: 1
D: 1
|
PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
U: 1
D: 1
|
PLSCR1 | phospholipid scramblase 1 |
U: 2
D: 1
|
PML | promyelocytic leukemia |
U: 15
D: 2
|
PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
D: 2
|
PRKCD | protein kinase C, delta |
U: 7
|
PRKN | parkin RBR E3 ubiquitin protein ligase |
U: 5
D: 1
|
PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
PTPRF | protein tyrosine phosphatase, receptor type, F |
U: 1
D: 1
|
RACK1 | receptor for activated C kinase 1 |
D: 1
|
RARB | retinoic acid receptor, beta |
U: 2
D: 1
|
RASGRF2 | Ras protein specific guanine nucleotide releasing factor 2 |
U: 1
|
RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 |
U: 1
D: 2
|
RBM5 | RNA binding motif protein 5 |
D: 2
|
REST | RE1-silencing transcription factor |
U: 2
|
RHOB | ras homolog family member B |
U: 3
D: 4
|
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
U: 1
|
RIPK2 | receptor (TNFRSF)-interacting serine-threonine kinase 2 |
U: 1
D: 1
|
RNF122 | ring finger protein 122 |
U: 1
|
RNPS1 | RNA binding protein with serine rich domain 1 |
U: 2
D: 1
|
RPS27A | ribosomal protein S27a |
U: 1
|
RPS6 | ribosomal protein S6 |
U: 2
D: 1
|
RPS6KA2 | ribosomal protein S6 kinase, polypeptide 2 |
U: 1
D: 2
|
RRP1B | ribosomal RNA processing 1 homolog B (S. cerevisiae) |
D: 1
|
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 |
U: 2
D: 2
|
RPS29 | ribosomal protein S29 |
U: 3
D: 1
|
RXRA | retinoid X receptor alpha |
U: 1
D: 3
|
S100B | S100 protein, beta polypeptide, neural |
D: 1
|
SAV1 | salvador family WW domain containing 1 |
D: 2
|
SCIN | scinderin |
U: 2
|
SCRIB | scribbled planar cell polarity |
U: 1
|
SFRP1 | secreted frizzled-related protein 1 |
U: 2
D: 1
|
SFRP2 | secreted frizzled-related protein 2 |
U: 2
D: 2
|
SFRP4 | secreted frizzled-related protein 4 |
U: 2
D: 1
|
SIRT1 | sirtuin 1 |
U: 12
D: 110
|
SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
U: 3
|
SLIT2 | slit guidance ligand 2 |
U: 1
D: 1
|
SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal |
U: 2
|
SNCA | synuclein alpha |
U: 3
|
SOD1 | superoxide dismutase 1 |
U: 5
D: 4
|
SOX4 | SRY (sex determining region Y)-box 4 |
U: 1
D: 1
|
SPHK2 | sphingosine kinase 2 |
D: 1
|
SQSTM1 | sequestosome 1 |
U: 15
D: 4
|
SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
STK17A | serine/threonine kinase 17a |
D: 1
|
STK17B | serine/threonine kinase 17b (apoptosis-inducing) |
D: 1
|
STK4 | serine/threonine kinase 4 |
U: 1
D: 1
|
STPG1 | sperm tail PG rich repeat containing 1 |
D: 1
|
SCP2 | sterol carrier protein 2, liver |
U: 1
|
SLK | STE20-like kinase |
U: 1
|
SMPD2 | sphingomyelin phosphodiesterase 2, neutral |
U: 1
D: 1
|
SP110 | Sp110 nuclear body protein |
U: 3
|
STEAP3 | STEAP family member 3 |
U: 3
D: 1
|
TCTN3 | tectonic family member 3 |
D: 1
|
TFAP4 | transcription factor AP4 |
D: 3
|
TFPT | TCF3 (E2A) fusion partner |
D: 1
|
TGFB3 | transforming growth factor, beta 3 |
U: 1
D: 3
|
TGM2 | transglutaminase 2, C polypeptide |
U: 6
D: 1
|
TIAM1 | TIAM Rac1 associated GEF 1 |
U: 3
D: 1
|
TIAM2 | TIAM Rac1 associated GEF 2 |
D: 1
|
TLR3 | toll like receptor 3 |
U: 4
D: 1
|
TNF | tumor necrosis factor |
U: 48
D: 7
|
TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 |
U: 1
|
TNFRSF10A | TNF receptor superfamily member 10a |
U: 1
D: 1
|
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b |
U: 3
D: 1
|
TNFRSF10C | TNF receptor superfamily member 10c |
U: 4
D: 1
|
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12a |
U: 3
D: 3
|
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1a |
U: 4
D: 2
|
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1b |
U: 3
D: 3
|
TNFRSF8 | tumor necrosis factor receptor superfamily, member 8 |
D: 1
|
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
U: 5
D: 3
|
TOMM22 | translocase of outer mitochondrial membrane 22 |
D: 2
|
TOP2A | topoisomerase (DNA) II alpha |
D: 10
|
TP53 | tumor protein p53 |
U: 243
D: 9
|
TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
U: 5
|
TRADD | TNFRSF1A associated via death domain |
U: 1
|
TRAF6 | TNF receptor associated factor 6 |
U: 1
D: 3
|
TRIM35 | tripartite motif-containing 35 |
U: 2
|
TRIO | trio Rho guanine nucleotide exchange factor |
U: 1
D: 2
|
TRPV1 | transient receptor potential cation channel, subfamily V, member 1 |
U: 2
|
TSPO | translocator protein |
U: 1
|
TXNIP | thioredoxin interacting protein |
U: 8
D: 6
|
TCF7L2 | transcription factor 7 like 2, T cell specific, HMG box |
U: 1
|
TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
TOMM40 | translocase of outer mitochondrial membrane 40 |
D: 2
|
TRP73 | transformation related protein 73 |
D: 3
|
TRPM7 | transient receptor potential cation channel, subfamily M, member 7 |
D: 1
|
TSC22D1 | TSC22 domain family, member 1 |
D: 1
|
UBB | ubiquitin B |
U: 1
D: 1
|
UBC | ubiquitin C |
D: 1
|
UBD | ubiquitin D |
U: 3
|
UBE2Z | ubiquitin-conjugating enzyme E2Z |
U: 2
D: 1
|
UNC13B | unc-13 homolog B |
U: 1
|
UNC5C | unc-5 netrin receptor C |
U: 1
D: 1
|
UTP11 | UTP11 small subunit processome component | |
UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats |
U: 1
D: 3
|
USP7 | ubiquitin specific peptidase 7 |
D: 2
|
VAV3 | vav guanine nucleotide exchange factor 3 |
U: 3
D: 2
|
VDR | vitamin D (1,25-dihydroxyvitamin D3) receptor |
U: 1
D: 2
|
WNT11 | wingless-type MMTV integration site family, member 11 |
U: 1
|
WDR35 | WD repeat domain 35 |
D: 2
|
WT1 | Wilms tumor 1 homolog |
D: 2
|
ZBTB16 | zinc finger and BTB domain containing 16 |
U: 1
D: 1
|
ZMAT3 | zinc finger matrin type 3 |
U: 4
D: 1
|
ZNF268 | zinc finger protein 268 |
D: 1
|
ZNF622 | zinc finger protein 622 |
U: 1
|